Google DeepMind and Indian Collaborations Tackle Diabetic Blindness
Transforming Diabetic Retinopathy Screening
Google has launched a significant initiative to aid in diabetic retinopathy screening in India, marking a pivotal shift in how we approach diabetic blindness. By collaborating with Forus Health and AuroLab, Google DeepMind licenses its innovative AI model to facilitate early detection of vision loss associated with diabetes.
AI Model Implementation
- The AI model is expected to support around six million screenings over the next decade.
- Screenings will be conducted at no cost to patients in resource-constrained areas of India and Thailand.
- This model has already assisted more than 600,000 screenings globally.
As part of this effort, Dr. Manish Gupta, Research Director at Google DeepMind, emphasizes the potential of AI in improving healthcare outcomes and reducing vision impairment.
Collaborative Efforts for Better Health
Google's initiative includes local regulatory collaboration to ensure compliance and effectiveness of the program. RD Sriram, Managing Director of AuroLab, expressed optimism about this technology preventing unnecessary vision loss and improving lives.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.